Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia
NCT02397356Phase 4Withdrawn
- Sponsor
- Tampere University Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative pain (2 arms), sponsored by Tampere University Hospital. Primary endpoint: Numerical Rating Scale Pain Score at 3 minutes. Planned start Aug 2018; status: withdrawn.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02397356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397356.